Price Target Analysis: Precision Drilling Corporation(NYSE:PDS): Pain Therapeutics, Inc.(NASDAQ:PTIE)

0
2

Precision Drilling Corporation (PDS) will report its next earnings on Oct 25 BMO. The company reported the earnings of $-0.06/Share in the last quarter where the estimated EPS by analysts was $-0.07/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 14.3%.

Many analysts are providing their Estimated Earnings analysis for Precision Drilling Corporation and for the current quarter 14 analysts have projected that the stock could give an Average Earnings estimate of $-0.05/share. These analysts have also projected a Low Estimate of $-0.07/share and a High Estimate of $-0.02/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for Precision Drilling Corporation as 308.31 Million. According to these analysts, the Low Revenue Estimate for Precision Drilling Corporation is 297.27 Million and the High Revenue Estimate is 330.91 Million. The company had Year Ago Sales of 272.18 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for PDS to be 33.3%. They are projecting Next Quarter growth of 100%. For the next 5 years, Precision Drilling Corporation is expecting Growth of 93.76% per annum, whereas in the past 5 years the growth was -3.57% per annum.

Some buy side analysts are also providing their Analysis on Precision Drilling Corporation, where 4 analysts have rated the stock as Strong buy, 4 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Precision Drilling Corporation might touch $6 high while the Average Price Target and Low price Target is $4.36 and $2.25 respectively.

Precision Drilling Corporation closed its last trading session at $2.17 with the gain of 0%. The Market Capitalization of the company stands at 642.8 Million. The Company has 52-week high of $4.14 and 52-week low of $2.17. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -11.84% where SMA50 and SMA200 are -21.76% and -33.25% respectively. The Company Touched its 52-Week High on 05/18/18 and 52-Week Low on 12/04/18.

The Relative Volume of the company is 0.72 and Average Volume (3 months) is 1.48 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -3.7%. The Return on Equity (ROE) value stands at -8%. While it’s Return on Investment (ROI) value is 0.1%.

While looking at the Stock’s Performance, Precision Drilling Corporation currently shows a Weekly Performance of -12.85%, where Monthly Performance is -9.96%, Quarterly performance is -39.04%, 6 Months performance is -34.83% and yearly performance percentage is -24.91%. Year to Date performance value (YTD perf) value is -28.15%. The Stock currently has a Weekly Volatility of 6.96% and Monthly Volatility of 5.91%.

Pain Therapeutics, Inc. (PTIE) will report its next earnings on Oct 29 AMC. The company reported the earnings of $-0.64/Share in the last quarter where the estimated EPS by analysts was $-0.47/share. The difference between the expected and actual EPS was $-0.17/share, which represents an Earnings surprise of -36.2%.

Many analysts are providing their Estimated Earnings analysis for Pain Therapeutics, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

Some buy side analysts are also providing their Analysis on Pain Therapeutics, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

Pain Therapeutics, Inc. closed its last trading session at $1.13 with the gain of 0%. The Market Capitalization of the company stands at 18.96 Million. The Company has 52-week high of $12.80 and 52-week low of $0.81. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.02% where SMA50 and SMA200 are -6.19% and -74.41% respectively. The Company Touched its 52-Week High on 01/09/18 and 52-Week Low on 08/21/18.

The Relative Volume of the company is 0.06 and Average Volume (3 months) is 2.18 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -63.1%. The Return on Equity (ROE) value stands at -68.4%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Pain Therapeutics, Inc. currently shows a Weekly Performance of 2.73%, where Monthly Performance is -7.38%, Quarterly performance is 16.41%, 6 Months performance is -88.45% and yearly performance percentage is -72.17%. Year to Date performance value (YTD perf) value is -71.75%. The Stock currently has a Weekly Volatility of 5.48% and Monthly Volatility of 5.96%.

SHARE